Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/01/1991 | US5053420 Thiazolidine derivatives for the treatment of hypertension |
10/01/1991 | US5053419 Administering calcium channel antagonists |
10/01/1991 | US5053418 Antiprotozoal agents |
10/01/1991 | US5053417 Imidazole derivatives and preparation thereof |
10/01/1991 | US5053416 Alzheimer's disease; central cholinomimetic activity |
10/01/1991 | US5053415 Pyridine derivatives |
10/01/1991 | US5053411 N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds |
10/01/1991 | US5053410 Combination of derivatives of pyrimidine and of nonsteroid antiinflammatory agents for inducing and stimulating the growth of hair and reducing its loss |
10/01/1991 | US5053408 Hexitol derivatives having vasodilative activity |
10/01/1991 | US5053407 Optically active pyridobenzoxazine derivatives and anti-microbial use |
10/01/1991 | US5053406 Compositions and methods for preventing and treating rotaviral infections |
10/01/1991 | US5053404 Novel steroid derivatives, pharmaceutical compositions containing them and process for preparing same |
10/01/1991 | US5053403 Methods for treatment of male-pattern baldness |
10/01/1991 | US5053402 Certain glyceryl phosphate-cyclic ammonium compounds useful for treating hypertension |
10/01/1991 | US5053401 Osteogenesis promotion with use of vitamin d derivatives |
10/01/1991 | US5053400 Anticoagulants; hypotensive agents; bronchodilator agents; tissue specificity |
10/01/1991 | US5053399 Myo-inositol analogs and methods for their use |
10/01/1991 | US5053398 Sulfated homopolysaccharides as anti-aids virus agents |
10/01/1991 | US5053396 For treatment of symptoms associated with excessive alcohol intake, analgesic; nicotinamide or nicotinamide adenine dinucleotide |
10/01/1991 | US5053395 Pradimicin amide derivatives |
10/01/1991 | US5053392 Anticoagulants |
10/01/1991 | US5053387 Feeding fish oil to reduce hypermetabolic state |
10/01/1991 | US5053229 Horny cell lipids with surface active agents enhances moisture retention of skin |
10/01/1991 | CA2079344A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
10/01/1991 | CA2039320A1 Biogenic amine uptake inhibitors |
10/01/1991 | CA2039319A1 Benzoxazine derivatives, process for their preparation and their use for the treatment of for the prophylaxis of diseases |
10/01/1991 | CA2038969A1 Compositions comprising cytotoxic agent and permeation enhancers |
10/01/1991 | CA2037433A1 Use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activity |
10/01/1991 | CA1290097C Peptide enzyme inhibitors |
10/01/1991 | CA1290096C Pharmaceutical compositions |
10/01/1991 | CA1289966C Antifungal tri-yne carbonates |
10/01/1991 | CA1289963C All-cis-1,3,5-triamino-2,4,6-cyclohexanetriol derivatives, their use, processes for their preparation and pharmaceutical preparations containing them |
10/01/1991 | CA1289962C 5-heterocyclic-2,4-dialkyl-3h-1,2,4-triazole-3- thiones and their use as antidepressants |
10/01/1991 | CA1289961C Quinolonecarboxylic acid derivative and process for its preparation |
10/01/1991 | CA1289958C Process for preparing novel n-substituted 3,4-dihydropyrimidine derivatives |
10/01/1991 | CA1289956C Naphthyridine- and quinolonecarboxylic acids as antibacterial agents |
10/01/1991 | CA1289955C Synthesis of 2-aminopyrimido¬4,5-g|quinolines |
10/01/1991 | CA1289954C Xanthine derivatives |
10/01/1991 | CA1289952C N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas, processes for their preparation, and their use in medicaments |
10/01/1991 | CA1289950C Antitumor anthracycline glycosides, their preparation, intermediates thereof, and compositions and use thereof |
10/01/1991 | CA1289949C Method for the preparation of 4'-0- tetrahydropyranyladriamycin b |
10/01/1991 | CA1289948C 12- and 13-substituted ergoline derivatives |
10/01/1991 | CA1289947C 1-alkyl ergolinylthiourea derivatives, process for the preparation thereof, as well as their use as medicinal agents |
10/01/1991 | CA1289944C 11 .beta.-(4-ISOPREPENYLPHENYL)ESTRA-4,9-DIENES, THEIR PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
10/01/1991 | CA1289904C Valiolamine derivatives and production thereof |
10/01/1991 | CA1289887C Composition containing gamma-linolenic acid and calcium |
10/01/1991 | CA1289886C Solutions of oxazaphosphorins having improved stability and process for the preparation thereof |
10/01/1991 | CA1289885C Tissue growth regulation |
10/01/1991 | CA1289884C ANTI-INFLAMMATORY MEDICAMENT HAVING A SYNERGISTIC ACTIVITY AND COMPRISING A CORTICOSTEROID AND A .beta.-AGONIST |
10/01/1991 | CA1289882C Method and compositions comprising a vitamin d derivative for the local treatment of bone fractures |
10/01/1991 | CA1289879C Compositions rich in oligoelements and processes for their manufacture |
09/30/1991 | WO1991014703A1 Hepatitis b vaccine |
09/30/1991 | WO1991014696A1 Oligonucleotide-transport agent disulfide conjugates |
09/30/1991 | WO1991014690A1 Unsaturated n-benzoxodiazopyranyl lactams, their production and use |
09/30/1991 | CA2079109A1 Oligonucleotide-transport agent disulfide conjugates |
09/30/1991 | CA2078139A1 Unsaturated n-benzoxadiazolopyranyllactams, the preparation and use thereof |
09/30/1991 | CA2039398A1 Propanobicyclic amine derivatives for cns disorders |
09/30/1991 | CA2039103A1 Improvements in and relating to the selective occupation of serotonin 1c receptors |
09/30/1991 | CA2039102A1 Compounds affecting serotonin receptors |
09/29/1991 | WO1991014681A1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
09/29/1991 | WO1991014680A1 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same |
09/29/1991 | WO1991014675A1 Bicyclo[3.3.)]octane derivatives, process for producing them and their pharmaceutical use |
09/29/1991 | CA2058922A1 Bicyclo{3.3.0}octane derivatives, process for their production and their pharmaceutical use |
09/29/1991 | CA2038716A1 Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method thereof and drug stabilized thereby |
09/29/1991 | CA2038692A1 Piperidine ether derivatives as psychotropic drugs or plant fungicides |
09/29/1991 | CA2038681A1 N-aralkyl piperidine derivatives as psychotropic drugs |
09/29/1991 | CA2013395A1 Aromatase inhibiting 4(5)-imidazoles |
09/28/1991 | WO1991014674A2 5-lipoxygenase inhibitors |
09/28/1991 | WO1991014671A1 New benzocycloalkene carboxylic acid and process for producing it |
09/28/1991 | WO1991014432A1 Supportive use |
09/28/1991 | CA2078126A1 5-lipoxygenase inhibitors |
09/28/1991 | CA2055602A1 Benzocycloalkenecarboxylic acid and process for it's preparation |
09/28/1991 | CA2039114A1 4h-pyrrolo[1,2-a]thieno[2,3-f]diazepine[1,4]derivatives, a process for their preparation and pharmaceutical compositions holding same |
09/28/1991 | CA2039055A1 Treatment of sinus headache |
09/27/1991 | WO1991014437A2 Use of copper(ii) containing compounds to accelerate wound healing |
09/27/1991 | CA2038962A1 Aminobenzene compounds, their production and use |
09/26/1991 | DE4009561A1 New anti-retroviral desoxy:nojirimycin derivs. |
09/26/1991 | DE4008858A1 New substd. purine antiviral cpds. |
09/25/1991 | EP0448523A2 Pharmaceutical compositions active on the cardiovascular system, containing 3-methylthiopropionyl L-carnitine |
09/25/1991 | EP0448393A1 Antihypercholesterolemics |
09/25/1991 | EP0448392A2 Xanthomegnin, a known compound, is an antiparasitic agent |
09/25/1991 | EP0448355A2 Antibiotic agents |
09/25/1991 | EP0448354A2 Lipopeptide derivatives |
09/25/1991 | EP0448300A2 Method and composition for coiontophoresis |
09/25/1991 | EP0448299A2 Composition for increased skin concentration of active agents by iontophoresis |
09/25/1991 | EP0448274A2 Use of a thromboxane A2 receptor antagonist for the manufacture of a medicament for the treatment of ulcerative gastrointestinal conditions |
09/25/1991 | EP0448261A2 Tenidap as an inhibitor of the release of elastase by neutrophils |
09/25/1991 | EP0448253A2 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
09/25/1991 | EP0448243A1 Milbemycin ether derivatives, their preparation and their therapeutic and agrochemical uses |
09/25/1991 | EP0448213A2 The use of retinoids to minimize skin damage |
09/25/1991 | EP0448128A2 Cembrane-type diterpene compounds for use in the production of compositions containing histamine release inhibitors |
09/25/1991 | EP0448091A2 Pharmaceutical composition containing slightly water-soluble drug |
09/25/1991 | EP0448035A1 Oleandomycin oximes, preparation and use thereof |
09/25/1991 | EP0448029A2 Novel pharmaceutical uses of forskolin derivatives |
09/25/1991 | EP0447962A1 Labdanes and process for their preparation |
09/25/1991 | EP0447938A1 Process for preparing 2-halogeno-3-hydroxy-3-phenyl-propionic acid ester compounds |
09/25/1991 | EP0447857A1 A polycyclic compound, method for preparing the same, and pharmaceutical composition comprising the same |
09/25/1991 | EP0447813A1 Water soluble salts of purpuromycin and pharmaceutical formulations thereof |
09/25/1991 | EP0447812A2 Use of a dihydropyridine to improve the inner ear blood circulation |
09/25/1991 | EP0447727A1 Novel 8-sulfamylmethylene-2-amino tetralins |